Sernova Biotherapeutics (TSX:SVA) Buyback Yield % : -7.55 (As of Mar. 03, 2025)

View and export this data going back to 1998. Start your Free Trial

What is Sernova Biotherapeutics Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Sernova Biotherapeutics's current buyback yield was -7.55%.

Sernova Biotherapeutics Buyback Yield % Historical Data

The historical data trend for Sernova Biotherapeutics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Biotherapeutics Buyback Yield % Chart

Sernova Biotherapeutics Annual Data

Trend

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

Buyback Yield %

Get a 7-Day Free Trial

-6.42

-6.47

-8.36

-6.10

Sernova Biotherapeutics Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Buyback Yield %	Get a 7-Day Free Trial															-	-	-	-	-6.10

Competitive Comparison of Sernova Biotherapeutics's Buyback Yield %

For the Biotechnology subindustry, Sernova Biotherapeutics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sernova Biotherapeutics's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's Buyback Yield % falls into.

Sernova Biotherapeutics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Sernova Biotherapeutics's Buyback Yield for the fiscal year that ended in Oct. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	4.96)	/	81.33125
	=	-6.10%

Sernova Biotherapeutics's annualized Buyback Yield for the quarter that ended in Oct. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	4.96)		/	81.33125
	=	-6.10%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Sernova Biotherapeutics Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (TSX:SVA) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

SEOVF:USA PSH0:Germany

Address

700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Executives